News und Analysen

In this video, I go over recent updates regarding Advanced Micro Devices (NASDAQ: AMD). Watch the short video to learn more, consider subscribing, and click the special offer link below.

*Stock

Aswath Damodaran teaches corporate finance and valuation at the Stern School of Business at New York University. In this podcast, Motley Fool Senior Analyst Matt Argersinger caught up with Damodaran

In today's video, I discuss Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), Intel (NASDAQ: INTC), other technology stocks, and recent updates affecting the semiconductor market. To

On Tuesday, investors continued to snap up shares of big pharmaceutical company Pfizer (NYSE: PFE). Somewhat counterintuitively, this week's rise came after the company announced it was ending the

No one ever claimed investing in the biotech industry was a smooth ride, but for shareholders of Viking Therapeutics (NASDAQ: VKTX), the turbulence has been extremely challenging thus far. The stock

Pfizer (NYSE: PFE) recently reminded investors how risky the drug-development business can be. On April 14, the company told investors it would scrap development of danuglipron, its oral GLP-1

Bad news for Pfizer (NYSE: PFE) turned into good news for Eli Lilly (NYSE: LLY), Novo Nordisk (NYSE: NVO), and Viking Therapeutics (NASDAQ: VKTX) Monday morning, each of which is rising on Pfizer's

When the stock market is as turbulent as it is these days, it's easy to forget the times when things are decidedly more cheery. However, sell-offs present great opportunities to buy stocks with

Pfizer's (NYSE: PFE) shares have been southbound for the better part of three years, partly because it was unable to repeat its incredible financial performance during the early pandemic years

Palantir Technologies (NASDAQ: PLTR) stock has returned 910% since the inception of the artificial intelligence boom in late 2022, and the company is currently worth $200 billion. But some Wall

Shares of IonQ (NYSE: IONQ) are surging this week. The company's stock had gained 25% over the week as I write this. The strong performance easily outpaced the S&P 500's most chaotic week in years.

After back-to-back years of strong returns for cruise line stocks, this year has been enough to make investors seasick. The three largest cruise line operators are trading 29%, 17%, and 35% lower in

There's a lot of uncertainty in the stock market and the U.S. economy right now, and that's probably putting it lightly. As the Trump administration implements new tariffs, businesses and consumers

As the stock market swings wildly thanks to erratic, unpredictable, and potentially economically damaging tariff policies from the Trump administration, predicting anything in the near term about

The stock market is off to a rough start to 2025. It's never fun to see the value of your portfolio dwindle, and there's never any certainty about when a period of market volatility will end. But

Vertex Pharmaceuticals (NASDAQ: VRTX) is a great example of biotech success. The company has built a cystic fibrosis (CF) empire, bringing in billions of dollars in revenue annually, and now is even

Shares of lung cancer-focused biotech Summit Therapeutics (NASDAQ: SMMT) rallied 16.6% at its highs of the day before settling into a 10.4% gain on Thursday as of 3:54 p.m. EDT, even though the

In today's video, I discuss Nvidia (NASDAQ: NVDA), Advanced Micro Devices (NASDAQ: AMD), and recent updates impacting the semiconductor market. To learn more, check out the short video, consider

In today's video, I discuss Broadcom (NASDAQ: AVGO), Advanced Micro Devices (NASDAQ: AMD), and Taiwan Semiconductor Manufacturing (NYSE: TSM). To learn more, check out the short video, consider

Viking Therapeutics (NASDAQ: VKTX) is a healthcare company that possesses a lot of growth potential. And last year, its shares rose by 116%, as investors were bullish on its prospects.

This year

Explore the exciting world of Advanced Micro Devices (NASDAQ: AMD) with our expert analysts in this Motley Fool Scoreboard episode. Check out the video below to gain valuable insights into market

Just like the rest of the stock market, pharmaceutical stocks are in a funk approaching the midweek mark, and it's looking like things might be about to get even worse for this particular pocket of

With equity markets in shambles due to President Donald Trump's trade policies, now might be as good a time as any to invest in excellent dividend stocks.

For one, dividend-paying companies tend to